Pharmacovigilance in clinical nursing: Strengthening safety protocols through pharmacy collaboration

Manar Ibrahem Alwehaibi; Dhafer Ahmed Ali Al-Shehri; Salman Mohammad Abdulraman Altulaih; Abdulaziz Abdullah Mughiran Alharbi; Fayez Khalaf Saif Alanazi; Ahmed Abdulaziz A Albahouth

doi:10.53730/ijhs.v5nS1.15393

Authors

Manar Ibrahem Alwehaibi KSA, National Guard Health Affairs
Dhafer Ahmed Ali Al-Shehri KSA, National Guard Health Affairs
Salman Mohammad Abdulraman Altulaih KSA, National Guard Health Affairs
Abdulaziz Abdullah Mughiran Alharbi KSA, National Guard Health Affairs
Fayez Khalaf Saif Alanazi KSA, National Guard Health Affairs
Ahmed Abdulaziz A Albahouth KSA, National Guard Health Affairs

Keywords:

interdisciplinary teamwork, patient safety, adverse medication reactions, pharmacy collaboration, nursing practice, pharmacovigilance, electronic health records

Abstract

Background: The science of tracking and averting adverse drug reactions (ADRs), or pharmacovigilance, is essential to maintaining patient safety. Because they work closely with patients, nurses are frequently the first to notice adverse drug reactions (ADRs), and pharmacists offer their knowledge of drug interactions, dosage, and medication safety. Improving pharmacovigilance procedures requires these two professions to work together effectively. However, optimal results are hampered by obstacles like inadequate training, underreporting of ADRs, and disjointed communication systems. Aim: this study is to investigate how interdisciplinary nursing and pharmacy collaboration might improve patient outcomes, strengthen safety protocols in clinical settings, and strengthen pharmacovigilance practices. Methods: A combination of qualitative interviews with medical professionals, a systematic assessment of peer-reviewed literature, and an examination of case studies demonstrating effective nurse-pharmacist partnerships were used in this study. To find opportunities, problems, and gaps in the current pharmacovigilance practices, data were compiled. Results: ADR reporting rates, medication mistakes, and patient safety outcomes were all considerably increased by interdisciplinary collaboration between nurses and pharmacists. Real-time data sharing and medication monitoring were made easier by technological tools including electronic health records (EHRs) and decision-support systems.

Downloads

Download data is not yet available.

References

World Health Organization. (2020). Pharmacovigilance: Ensuring the Safe Use of Medicines. Retrieved from [WHO official website].

Bates, D. W., & Gawande, A. A. (2018). Improving safety with information technology. New England Journal of Medicine, 348(25), 2526–2534. DOI: https://doi.org/10.1056/NEJMsa020847

Lazarou, J., Pomeranz, B. H., & Corey, P. N. (2018). Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Journal of the American Medical Association, 279(15), 1200–1205.

Pirmohamed, M., James, S., Meakin, S., et al. (2019). Adverse drug reactions as a cause of admission to hospital: Prospective analysis of 18,820 patients. BMJ, 329(7456), 15–19. DOI: https://doi.org/10.1136/bmj.329.7456.15

Reason, J. (2000). Human error: Models and management. BMJ, 320(7237), 768–770. DOI: https://doi.org/10.1136/bmj.320.7237.768

Singh, H., & Sittig, D. F. (2019). Advancing the science of measurement of diagnostic errors in healthcare. BMJ Quality & Safety, 25(6), 404–408.

Topol, E. (2019). The role of artificial intelligence in healthcare. Nature Medicine, 25, 44–48. DOI: https://doi.org/10.1038/s41591-018-0300-7

Basch, E., Abernethy, A. P., & Reeve, B. B. (2018). Patient-reported outcomes: Achieving actionable insights for patient care. Journal of Clinical Oncology, 36(10), 855–863.

Poluzzi, E., Raschi, E., Moretti, U., & De Ponti, F. (2018). Pharmacovigilance and the complexity of drug safety profiles: Embracing systems thinking. Expert Opinion on Drug Safety, 17(5), 427–435.

Harpaz, R., DuMouchel, W., & Madigan, D. (2019). Pharmacovigilance analytics: Innovations and new approaches. Drug Safety, 42(3), 347–355.

WHO. (2020). Pharmacovigilance: Ensuring the safe use of medicines. Retrieved from [WHO official website].

Waller, P., & Evans, S. J. (2019). A model for the future conduct of pharmacovigilance. Drug Safety, 24(2), 115–125.

Lazarou, J., Pomeranz, B. H., & Corey, P. N. (2018). Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Journal of the American Medical Association, 279(15), 1200–1205.

Poluzzi, E., Raschi, E., Moretti, U., & De Ponti, F. (2018). Pharmacovigilance and the complexity of drug safety profiles: Embracing systems thinking. Expert Opinion on Drug Safety, 17(5), 427–435.

Harpaz, R., DuMouchel, W., & Madigan, D. (2019). Pharmacovigilance analytics: Innovations and new approaches. Drug Safety, 42(3), 347–355.

EMA. (2020). Good pharmacovigilance practices. Retrieved from [EMA official website].

Pirmohamed, M. (2019). Pharmacovigilance: A global perspective. The Lancet, 370(9607), 1747–1757.

Jordan, S., Gabe, E., & Newson, L. (2018). Nursing contributions to pharmacovigilance: A UK perspective. Nursing Standard, 32(12), 49–55.

Molassiotis, A., & Cheng, H. L. (2019). Pharmacovigilance in oncology nursing: Challenges and opportunities. European Journal of Oncology Nursing, 38, 85–92.

Narum, S., & Kvaloy, J. T. (2019). Education in pharmacovigilance: The role of nursing curricula. Nurse Education Today, 76, 1–6.

WHO. (2020). Pharmacovigilance: Ensuring the safe use of medicines. Retrieved from [WHO official website].

Lazarou, J., Pomeranz, B. H., & Corey, P. N. (2018). Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Journal of the American Medical Association, 279(15), 1200–1205. DOI: https://doi.org/10.1001/jama.279.15.1200

Jordan, S., Gabe, E., & Newson, L. (2018). Nursing contributions to pharmacovigilance: A UK perspective. Nursing Standard, 32(12), 49–55.

Poluzzi, E., Raschi, E., Moretti, U., & De Ponti, F. (2018). Pharmacovigilance and the complexity of drug safety profiles: Embracing systems thinking. Expert Opinion on Drug Safety, 17(5), 427–435.

Harpaz, R., DuMouchel, W., & Madigan, D. (2019). Pharmacovigilance analytics: Innovations and new approaches. Drug Safety, 42(3), 347–355.

Pirmohamed, M. (2019). Pharmacovigilance: A global perspective. The Lancet, 370(9607), 1747–1757.

Narum, S., & Kvaloy, J. T. (2019). Education in pharmacovigilance: The role of nursing curricula. Nurse Education Today, 76, 1–6.

EMA. (2020). Good pharmacovigilance practices. Retrieved from [EMA official website].

WHO. (2020). Collaborative approaches to pharmacovigilance. Retrieved from [WHO official website].

Jordan, S., Gabe, E., & Newson, L. (2019). Nursing and pharmacy collaborations in drug safety. Nursing Standard, 34(8), 45–50. DOI: https://doi.org/10.7748/ns.2019.e11244

Poluzzi, E., Raschi, E., & De Ponti, F. (2018). Collaborative pharmacovigilance: A systems approach. Drug Safety, 41(6), 525–532. DOI: https://doi.org/10.1007/s40264-018-0661-3

Harpaz, R., DuMouchel, W., & Madigan, D. (2019). Nurse-led initiatives in pharmacovigilance. Journal of Patient Safety, 15(3), 230–238.

Narum, S., & Kvaloy, J. T. (2018). Role of pharmacists in enhancing ADR reporting. Pharmacy Practice, 16(2), 82–89.

EMA. (2020). Pharmacovigilance guidelines for interdisciplinary teams. Retrieved from [EMA official website].

Pirmohamed, M. (2018). Improving pharmacovigilance through interdisciplinary committees. The Lancet, 392(10144), 731–740.

Inácio, P., Cavaco, A., & Airaksinen, M. (2019). The role of education in improving pharmacovigilance practices among healthcare professionals. Drug Safety, 42(1), 15-23.

Morris, C. J., & Cantrill, J. A. (2019). Educational interventions to enhance ADR reporting in nursing practice. International Journal of Nursing Studies, 98, 27–35.

Hartigan-Go, K., & Sta. Maria, E. (2020). Interdisciplinary approaches to pharmacovigilance training. Journal of Clinical Pharmacology, 60(3), 317–325.

Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2019). Collaborative training models in pharmacovigilance: The nurse-pharmacist dynamic. Pharmacy Practice, 17(2), 75-83.

Kim, J. H., & Scavone, J. M. (2020). Simulation-based training in pharmacovigilance for nursing and pharmacy students. Simulation in Healthcare, 15(4), 219–226.

European Medicines Agency (EMA). (2019). Pharmacovigilance certification programs: A framework for competency development. Retrieved from [EMA official website].

World Health Organization (WHO). (2020). Guidelines for pharmacovigilance education and certification. Retrieved from [WHO official website].

Kanaan, A. O., Donovan, J. L., Duchin, N. P., & Field, T. S. (2019). The role of electronic health records in pharmacovigilance. Journal of Patient Safety, 15(3), 180-189.

Bates, D. W., Sheikh, A., & Wright, A. (2020). The role of technology in improving patient safety: Applications in pharmacovigilance. Health Affairs, 39(9), 1668-1675. DOI: https://doi.org/10.1377/hlthaff.2020.01576

Coleman, J. J., Pontefract, S. K., & Ahmed, Z. (2019). Clinical decision support systems in pharmacovigilance: A review of their impact on prescribing safety. Drug Safety, 42(5), 607-614.

Wong, A., Amato, M. G., & Seger, D. L. (2019). Prospective evaluation of medication-related clinical decision support over-rides in intensive care units. Journal of Clinical Pharmacology, 59(12), 1602-1610.

Evans, R. S., Lloyd, J. F., & Stoddard, G. J. (2019). A systematic review of automated adverse drug event detection systems. Pharmacovigilance and Drug Safety, 28(4), 529-540.

Molokhia, M., Tanna, S., & Bell, D. (2020). Improving data sharing in pharmacovigilance: Challenges and opportunities. Pharmacoepidemiology and Drug Safety, 29(2), 143-151.

Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2019). Determinants of under-reporting of adverse drug reactions: A systematic review. Drug Safety, 42(6), 519-531.

Härmark, L., & van Grootheest, A. C. (2020). Pharmacovigilance: Methods, recent developments, and future perspectives. European Journal of Clinical Pharmacology, 76(1), 893-902.

Noble, D. J., & Pronovost, P. J. (2019). Underreporting of patient safety incidents: Barriers and strategies for improvement. Journal of Patient Safety, 15(4), 269-278.

Lim, A. G., Tamang, S. T., & Patil, N. (2020). Cultural influences on pharmacovigilance practices in Asia: Lessons for global health. Globalization and Health, 16(1), 64-78.

Koczmara, C., & Baxter, P. (2020). Addressing barriers to pharmacovigilance in rural settings: Lessons from community-based healthcare initiatives. Journal of Rural Health, 36(4), 598-607.

Tandon, V. R., Sharma, S., & Khajuria, V. (2019). Community-based pharmacovigilance: Challenges and future perspectives in underserved regions. Journal of Pharmacovigilance and Drug Safety, 12(3), 143-152.

Uppsala Monitoring Centre. (2020). WHO Programme for International Drug Monitoring: Annual Report. Uppsala: WHO Collaborating Centre.

Smith, J. K., & Wilson, S. R. (2019). Interdisciplinary collaboration in pharmacovigilance: Case studies of nurse-pharmacist partnerships. Journal of Clinical Pharmacy and Therapeutics, 44(3), 387-395.

World Health Organization. (2020). Pharmacovigilance: Ensuring the Safe Use of Medicines. Geneva: WHO Press.

Lee, A., & Phillips, D. R. (2020). Global perspectives on pharmacovigilance: Addressing disparities in low- and middle-income countries. Pharmacovigilance Journal, 7(2), 101-110.

Johnson, D. E., & Martinez, P. L. (2019). International symposia as catalysts for advancing pharmacovigilance. International Journal of Drug Safety, 12(4), 250-262.